Genprex, Inc.(GNPX)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
GNPX Stock Analysis & AI Quality Score
Data updated 2026-07-26AI stock analysis and institutional research for Genprex, Inc. (GNPX), a Healthcare sector company. GNPX is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of GNPX by reported 13-F value include VANGUARD FIDUCIARY, HRT FINANCIAL, GEODE CAPITAL MANAGEMENT, based on the most recent SEC filings. GNPX trades on the Nasdaq exchange and files with the SEC under CIK 1595248. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate GNPX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Genprex, Inc. directly from SEC EDGAR.
Net Income
Q2 2026
$-4.4M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
Net Income
+23.1% YoYOperating Income
+26.7% YoYTotal Assets
+146.3% YoYOp. Cash Flow
+14.6% YoYFree Cash Flow
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | $-16.2M +23.1% | $-21.1M +31.6% | $-30.9M -30.0% | $-23.7M -14.9% | $-20.7M -15.2% | $-17.9M |
| Operating Income | $-15.5M +26.7% | $-21.2M +31.8% | $-31.1M -30.3% | $-23.8M -15.3% | $-20.7M -15.1% | $-18.0M |
| Total Assets | $10.2M +146.3% | $4.1M -61.3% | $10.7M -57.5% | $25.1M -41.5% | $42.9M +36.6% | $31.4M |
| Operating Cash Flow | $-15.3M +14.6% | $-17.9M +27.6% | $-24.7M -40.4% | $-17.6M -23.4% | $-14.3M -2.5% | $-13.9M |
| Free Cash Flow | — | — | — | $-17.6M -23.1% | $-14.3M -2.6% | $-14.0M |
Get alerted when GNPX's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Genprex, Inc. including:
Top Institutional Holders of GNPX
VANGUARD FIDUCIARY TRUST CO
$40.5K78,104 shHRT FINANCIAL LP
$37.0K72,061 shGEODE CAPITAL MANAGEMENT, LLC
$31.3K60,348 shVANGUARD CAPITAL MANAGEMENT LLC
$18.9K36,350 shEngineers Gate Manager LP
$10.8K20,885 shMayflower Financial Advisors, LLC
$10.4K20,000 shUBS Group AG
$2.3K4,489 shTower Research Capital LLC (TRC)
$1.5K2,847 shBARCLAYS PLC
$819.001,578 shJONES FINANCIAL COMPANIES LLLP
$597.001,208 sh
| Fund | Value | Shares |
|---|---|---|
| VANGUARD FIDUCIARY TRUST CO | $40.5K | 78,104 |
| HRT FINANCIAL LP | $37.0K | 72,061 |
| GEODE CAPITAL MANAGEMENT, LLC | $31.3K | 60,348 |
| VANGUARD CAPITAL MANAGEMENT LLC | $18.9K | 36,350 |
| Engineers Gate Manager LP | $10.8K | 20,885 |
| Mayflower Financial Advisors, LLC | $10.4K | 20,000 |
| UBS Group AG | $2.3K | 4,489 |
| Tower Research Capital LLC (TRC) | $1.5K | 2,847 |
| BARCLAYS PLC | $819.00 | 1,578 |
| JONES FINANCIAL COMPANIES LLLP | $597.00 | 1,208 |
More Healthcare Companies
View all Healthcare →Put GNPX on your watchlist
Track score changes the day Genprex, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is GNPX a good stock to buy?
13F Pro's AI-powered analysis of Genprex, Inc. (GNPX) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for GNPX are available on the GNPX stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. GNPX is classified as a small company.
Which hedge funds own GNPX?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling GNPX. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Genprex, Inc.'s investment landscape.